Machine learning–guided single-cell multiomics uncovers GDF15-driven immunosuppressive niches in NSCLC: A translational framework for overcoming anti-PD-1 resistance
Immune checkpoint blockade (ICB) has transformed non-small cell lung cancer (NSCLC) treatment, but durable clinical responses remain limited, underscoring the need for robust predictive biomarkers. We integrated multiomics profiling with machine learning to systematically identify determinants of IC...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Translational Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523325001901 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850108776485486592 |
|---|---|
| author | Xianfei Zhang Zhengxin Yin Xueyu Chen Nengchong Zhang Shengjia Yu Congcong Zhu Lianggang Zhu Liulan Shao Bin Li Runsen Jin Hecheng Li |
| author_facet | Xianfei Zhang Zhengxin Yin Xueyu Chen Nengchong Zhang Shengjia Yu Congcong Zhu Lianggang Zhu Liulan Shao Bin Li Runsen Jin Hecheng Li |
| author_sort | Xianfei Zhang |
| collection | DOAJ |
| description | Immune checkpoint blockade (ICB) has transformed non-small cell lung cancer (NSCLC) treatment, but durable clinical responses remain limited, underscoring the need for robust predictive biomarkers. We integrated multiomics profiling with machine learning to systematically identify determinants of ICB efficacy. Comparative evaluation of 22 survival algorithms across four NSCLC cohorts (n=156) led to the development of an Accelerated Oblique Random Survival Forest model, which outperformed conventional Cox regression and deep learning methods in predictive accuracy (training C-index=0.864; test C-index=0.748). Single-cell RNA sequencing of an immunotherapy-treated cohort revealed that high-risk tumors harbor malignant epithelial subclusters expressing growth differentiation factor 15 (GDF15), a transforming growth factor-β superfamily member implicated in immune evasion. Single-cell non-negative matrix factorization identified GDF15 as a network hub regulating proliferative dominance. External validation using melanoma cohorts (GSE91061) confirmed the pan-cancer predictive relevance of GDF15 and its associated tumor cluster. Functional studies utilizing GDF15-knockdown Lewis lung carcinoma cells showed no significant effect on intrinsic tumor proliferation or growth under immune stress (both p>0.05). GDF15 deletion significantly potentiated PD-1 inhibitor efficacy in vivo, reducing tumor mass by 94.41±6.53 % (SH1) and 94.54±5.21 % (SH2) compared with 3.39±54.90 % in empty vector controls (p<0.01 for all comparisons). CD8+ T cell infiltration was also substantially enhanced (81.62±4.79 % [SH1] and 123.50±10.02 % [SH2] vs. 29.63±22.17 % [EV], p<0.05). These findings implicate GDF15 as a regulator of the immunosuppressive tumor microenvironment. Our findings position GDF15 as a first-in-class biomarker for predicting ICB resistance; they establish a translational framework that bridges computational prediction with single-cell mechanistic insights to inform NSCLC immunotherapy. |
| format | Article |
| id | doaj-art-14920c67daae40df9e616355a014b733 |
| institution | OA Journals |
| issn | 1936-5233 |
| language | English |
| publishDate | 2025-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Translational Oncology |
| spelling | doaj-art-14920c67daae40df9e616355a014b7332025-08-20T02:38:15ZengElsevierTranslational Oncology1936-52332025-09-015910245910.1016/j.tranon.2025.102459Machine learning–guided single-cell multiomics uncovers GDF15-driven immunosuppressive niches in NSCLC: A translational framework for overcoming anti-PD-1 resistanceXianfei Zhang0Zhengxin Yin1Xueyu Chen2Nengchong Zhang3Shengjia Yu4Congcong Zhu5Lianggang Zhu6Liulan Shao7Bin Li8Runsen Jin9Hecheng Li10Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of MedicineDepartment of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of MedicineDepartment of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of MedicineDepartment of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of MedicineDepartment of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of MedicineDepartment of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of MedicineDepartment of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of MedicineDepartment of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of MedicineCenter for Immune-Related Diseases at Shanghai Institute of Immunology, Department of Respiratory and Critical Care Medicine of Ruijin Hospital, Department of Thoracic Surgery of Ruijin Hospital, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Corresponding author at: Center for Immune-Related Diseases at Shanghai Institute of Immunology, Department of Respiratory and Critical Care Medicine of Ruijin Hospital, Department of Thoracic Surgery of Ruijin Hospital, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine; Corresponding authors at: Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, China.Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine; Corresponding authors at: Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, China.Immune checkpoint blockade (ICB) has transformed non-small cell lung cancer (NSCLC) treatment, but durable clinical responses remain limited, underscoring the need for robust predictive biomarkers. We integrated multiomics profiling with machine learning to systematically identify determinants of ICB efficacy. Comparative evaluation of 22 survival algorithms across four NSCLC cohorts (n=156) led to the development of an Accelerated Oblique Random Survival Forest model, which outperformed conventional Cox regression and deep learning methods in predictive accuracy (training C-index=0.864; test C-index=0.748). Single-cell RNA sequencing of an immunotherapy-treated cohort revealed that high-risk tumors harbor malignant epithelial subclusters expressing growth differentiation factor 15 (GDF15), a transforming growth factor-β superfamily member implicated in immune evasion. Single-cell non-negative matrix factorization identified GDF15 as a network hub regulating proliferative dominance. External validation using melanoma cohorts (GSE91061) confirmed the pan-cancer predictive relevance of GDF15 and its associated tumor cluster. Functional studies utilizing GDF15-knockdown Lewis lung carcinoma cells showed no significant effect on intrinsic tumor proliferation or growth under immune stress (both p>0.05). GDF15 deletion significantly potentiated PD-1 inhibitor efficacy in vivo, reducing tumor mass by 94.41±6.53 % (SH1) and 94.54±5.21 % (SH2) compared with 3.39±54.90 % in empty vector controls (p<0.01 for all comparisons). CD8+ T cell infiltration was also substantially enhanced (81.62±4.79 % [SH1] and 123.50±10.02 % [SH2] vs. 29.63±22.17 % [EV], p<0.05). These findings implicate GDF15 as a regulator of the immunosuppressive tumor microenvironment. Our findings position GDF15 as a first-in-class biomarker for predicting ICB resistance; they establish a translational framework that bridges computational prediction with single-cell mechanistic insights to inform NSCLC immunotherapy.http://www.sciencedirect.com/science/article/pii/S1936523325001901Lung cancerImmunotherapyGrowth differentiation factor 15Programmed cell death protein 1 |
| spellingShingle | Xianfei Zhang Zhengxin Yin Xueyu Chen Nengchong Zhang Shengjia Yu Congcong Zhu Lianggang Zhu Liulan Shao Bin Li Runsen Jin Hecheng Li Machine learning–guided single-cell multiomics uncovers GDF15-driven immunosuppressive niches in NSCLC: A translational framework for overcoming anti-PD-1 resistance Translational Oncology Lung cancer Immunotherapy Growth differentiation factor 15 Programmed cell death protein 1 |
| title | Machine learning–guided single-cell multiomics uncovers GDF15-driven immunosuppressive niches in NSCLC: A translational framework for overcoming anti-PD-1 resistance |
| title_full | Machine learning–guided single-cell multiomics uncovers GDF15-driven immunosuppressive niches in NSCLC: A translational framework for overcoming anti-PD-1 resistance |
| title_fullStr | Machine learning–guided single-cell multiomics uncovers GDF15-driven immunosuppressive niches in NSCLC: A translational framework for overcoming anti-PD-1 resistance |
| title_full_unstemmed | Machine learning–guided single-cell multiomics uncovers GDF15-driven immunosuppressive niches in NSCLC: A translational framework for overcoming anti-PD-1 resistance |
| title_short | Machine learning–guided single-cell multiomics uncovers GDF15-driven immunosuppressive niches in NSCLC: A translational framework for overcoming anti-PD-1 resistance |
| title_sort | machine learning guided single cell multiomics uncovers gdf15 driven immunosuppressive niches in nsclc a translational framework for overcoming anti pd 1 resistance |
| topic | Lung cancer Immunotherapy Growth differentiation factor 15 Programmed cell death protein 1 |
| url | http://www.sciencedirect.com/science/article/pii/S1936523325001901 |
| work_keys_str_mv | AT xianfeizhang machinelearningguidedsinglecellmultiomicsuncoversgdf15drivenimmunosuppressivenichesinnsclcatranslationalframeworkforovercomingantipd1resistance AT zhengxinyin machinelearningguidedsinglecellmultiomicsuncoversgdf15drivenimmunosuppressivenichesinnsclcatranslationalframeworkforovercomingantipd1resistance AT xueyuchen machinelearningguidedsinglecellmultiomicsuncoversgdf15drivenimmunosuppressivenichesinnsclcatranslationalframeworkforovercomingantipd1resistance AT nengchongzhang machinelearningguidedsinglecellmultiomicsuncoversgdf15drivenimmunosuppressivenichesinnsclcatranslationalframeworkforovercomingantipd1resistance AT shengjiayu machinelearningguidedsinglecellmultiomicsuncoversgdf15drivenimmunosuppressivenichesinnsclcatranslationalframeworkforovercomingantipd1resistance AT congcongzhu machinelearningguidedsinglecellmultiomicsuncoversgdf15drivenimmunosuppressivenichesinnsclcatranslationalframeworkforovercomingantipd1resistance AT lianggangzhu machinelearningguidedsinglecellmultiomicsuncoversgdf15drivenimmunosuppressivenichesinnsclcatranslationalframeworkforovercomingantipd1resistance AT liulanshao machinelearningguidedsinglecellmultiomicsuncoversgdf15drivenimmunosuppressivenichesinnsclcatranslationalframeworkforovercomingantipd1resistance AT binli machinelearningguidedsinglecellmultiomicsuncoversgdf15drivenimmunosuppressivenichesinnsclcatranslationalframeworkforovercomingantipd1resistance AT runsenjin machinelearningguidedsinglecellmultiomicsuncoversgdf15drivenimmunosuppressivenichesinnsclcatranslationalframeworkforovercomingantipd1resistance AT hechengli machinelearningguidedsinglecellmultiomicsuncoversgdf15drivenimmunosuppressivenichesinnsclcatranslationalframeworkforovercomingantipd1resistance |